Skip to content
Brand AI

HALIX B.V.

Request correction

Corporate brand

Unclaimed

HALIX is a contract development and manufacturing organization (CDMO) focused on mammalian expression systems for viral vectors, vaccines, and recombinant proteins.

Last updated September 1, 2026

AI crawler reads

No AI crawler has read this profile yet.

Overview

HALIX B.V. is a biotech contract development and manufacturing organization (CDMO) in the Netherlands, established in 2012 as a spin-off of HAL Allergy. It is located in the Leiden Bio Science Park and provides development and manufacturing solutions for viral vectors, vaccines, and recombinant proteins, serving customers from small startups to big pharma.

History

HALIX was established in 2012 as a spin-off of HAL Allergy, leveraging HAL's industry experience and GMP expertise. It is a fast-growing CDMO focused on mammalian expression systems for viral vectors, viral vector vaccines, and recombinant proteins, located in the Leiden Bio Science Park in the Netherlands.

Sources4 sources

  1. 1HALIX | the Healthcare CDMO | Biologics - viral vectors and proteinshalix.nl
  2. 2About HALIX | GMP Contract Manufacturing & Development | Mammalianhalix.nl
  3. 3Company Information - Halix | Bioscience as a servicehalix.nl
  4. 4HALIX B.V.wikidata.org

Cite this profile: Cite the canonical profile. /brand-wiki/halix-bv · Editorial policy · How profiles are compiled